We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase 1 U.S. Trial of COVID-19 DNA Vaccine Enrollment Complete

Product News   May 05, 2020

 
Phase 1 U.S. Trial of COVID-19 DNA Vaccine Enrollment Complete
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Canada’s Largest Research Hospital Selects ImmunoGenomiX Platform To Analyze Immune Sequencing Data

Product News

ENPICOM, an innovative bioinformatics software engineering company specialized in decoding the immune system, announced that the Princess Margaret Cancer Centre of the University Health Network (UHN) has purchased a subscription to ENPICOM’s data analysis platform.

READ MORE

Phase III Trial of Janssen's COVID-19 Vaccine Launched

Product News

Johnson & Johnson today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

READ MORE

IDBS Works With SCIEX To Launch Analyst™ Software Integration

Product News

IDBS announced that it has released a fully-featured integration between the E-WorkBook electronic laboratory notebook (ELN) and SCIEX Analyst® Software, expanding IDBS’s existing family of integrations. This new integration strengthens preclinical capabilities and enables increased regulatory compliance and improved throughput.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE